Conference abstract · 11 Jun 2018
Conference abstractPublished 29 Jun 2017
Current Challenges on Chagas Disease
Faculty of Health Sciences, Anahuac University North Campus, Mexico.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chagas disease or American trypanosomiasis is recognized by the World Health Organization as one of the 18 Neglected Tropical Diseases. It is estimated that there are between 7–8 million people infected, between 65–100 million people at risk of becoming infected and it causes nearly 12,000 deaths per year worldwide. Chagas disease is endemic of 21 Latin American countries, but the expanding migrational flows have male the disease an international health priority. It is a parasitic zoonosis caused by Trypanosoma cruzi, a protozoan with high genetic and phenotypic diversity that can be principally transmitted to human beings by the faeces of blood-sucking triatomines. Other mechanisms of transmission include; blood transfusions, organ or bone marrow transplants, from mother to child, by ingestion of food or drinks contaminated with triatomine faeces and due to occupational exposure. Chagas disease has a very broad-spectrum of clinical manifestations, depending upon the phase at where the patient is. Acute phase is characterized for passing unnoticed in 95% of the cases, unless Romaña’s sign or chagoma develops at the inoculation site. Chronic phase is characterized for developing cardiac or gastrointestinal disease that lead to increased morbi-mortality. Diagnosis can be done with the combination of epidemiological background and clinical manifestations, if present, but laboratory tests are required for confirmation. Benznidazole and Nifurtimox are the only drugs available for treating the disease and meanwhile the efforts to formulate vaccines remain insufficient, patients suffer from a preventable disease which main risk factor for acquiring it is living in poor and marginalised societies. Control of vector-borne transmission remains to be a challenge in endemic countries as it is related to low socioeconomic status, while serological screening at blood banks and monitoring of all pregnant women for non vector-borne transmission can be effective to control the disease in non-endemic countries
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 4 Aug 2023
Chagas Disease beyond Endemic Borders: Challenges and Implications
Short communication · Sep 2020
Advances and challenges in the anti-parasitic treatment of Chagas disease
Conference abstract
Experimental chagas disease: Vaccination with Trypanosoma rangeli modulate the innate immune response in mice challenged with Trypanosoma cruzi
Short communication · 31 Mar 2025
Histopathological Evaluation of Inflammatory Bowel Disease: Current Trends and Challenges
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Jorge-Alberto Ascencio-Aragón”
